US Market for Coronary Vascular Closure 2015 – MedCore

US Market for Coronary Vascular Closure 2015 – MedCore

0

  • Year: 2015
  • Scope: 2011-2021
  • Region: United States
  • Published Date: 12/01/2015
  • Pages: 44
  • Type: MedCore

Vascular closure devices (VCDs) are used in both the peripheral and coronary markets for minimally invasive cardiovascular therapies, which has created a large market for post-procedural VCDs. The introduction of a catheter into the arterial system, to place a stent for example, is much less traumatic for the patient than a comparable surgical intervention, with only a hole created in the artery (generally the femoral) for access. This access hole will bleed profusely if unmanaged, and therefore some form of vascular closure is required.

The gold standard in this market is manual compression. Although effective, this approach is wasteful of man-power, with perhaps 20 minutes to several hours of compression time required. With the general shortage of nursing labor, many hospitals are finding it cost-effective to employ VCDs to accelerate the closure process.
This chapter only covers the market for closure devices that were used in association with coronary procedures.
3.1.1 Invasive and Non-Invasive Devices
There are two types of vascular closure devices: invasive and non-invasive. Invasive devices operate by inserting a device component into the arterial hole and causing closure by various mechanisms (including sutures and collagen sponges). Non-invasive devices act at the exterior of the skin to achieve hemostasis. In addition, there are two main forms of non-invasive devices: patches and inflatable pressure bulbs.



The "European Markets for Interventional Cardiology Devices 2015 - MedSuite" includes analysis on the following companies currently active in this market:
Boston Scientific
Abbott Laboratories
Medtronic
Biotronik
St. Jude Medical
Cordis
Terumo
Volcano Therapeutics
B. Braun
Hexacath
Biosensors
Others include: Blue Medical, Bolton Medical, Cardiovascular Systems Inc, C.R. Bard, Elixir Medical Corp, Invatec

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Thank you!

CLOSE
Report Type Info

Single License: A single license is for use by a single individual only. Usage rights may not be transferred, sold or distributed by any means.

Site License: A site license allows sharing of the reports between various users within the purchasing company’s designated business address within this agreement.

Corporate License: A corporate license is for the use of one corporation. A corporation is defined as any business entity incorporated under a single name. Separate corporations operating under the same parent company are not included in this license.

Executive Summary: An in-depth summary of the reports associated with the related MedSuite product.

CLOSE

Login

Sign Up

Already have an account? Sign in

×